New Antidepressant Treatment Involves Transcranial Magnetic Stimulation
Title:
New Antidepressant Treatment Involves Transcranial Magnetic Stimulation
Word Count:
496
Summary:
Transcranial Magnetic Stimulation is an antidepression treatment that is noninvasive and admin
Keywords:
antidepressant treatment
Article Body:
Transcranial magnetic stimulation (TMS) is an experimental antidepression treatment that prove
Though the experiment has not been approved by the FDA for antidepression treatment, an adviso
TMS is a noninvasive procedure that requires no anesthesia and administered in an outpatient s
Three hundred one patients with major depression who had failed to respond to antidepressant d
According to research report appearing in the December issue of the Biological Psychiatry jour
While researcher John P. O’Reardon, MD, concedes that response and remission rates were relati
Between 14% and 17% of patients on the active treatment had achieved a remission after six wee
ˆIn a less-resistant population we would expect to see higher responses,˜ said O’Reardon.
Although TMS treatments are typically given five times a week, patients usually need a minimum
When the FDA advisory panel met in January of this year to consider TMS, officials with the ag
There are still very few centers around the country that offer TMS as antidepression treatment
This is a demo version of txt2pdf v.10.1
Developed by SANFACE Software http://www.sanface.com/
Available at http://www.sanface.com/txt2pdf.html
New Antidepressant Treatment Involves Transcranial Magnetic Stimulation
Word Count:
496
Summary:
Transcranial Magnetic Stimulation is an antidepression treatment that is noninvasive and admin
Keywords:
antidepressant treatment
Article Body:
Transcranial magnetic stimulation (TMS) is an experimental antidepression treatment that prove
Though the experiment has not been approved by the FDA for antidepression treatment, an adviso
TMS is a noninvasive procedure that requires no anesthesia and administered in an outpatient s
Three hundred one patients with major depression who had failed to respond to antidepressant d
According to research report appearing in the December issue of the Biological Psychiatry jour
While researcher John P. O’Reardon, MD, concedes that response and remission rates were relati
Between 14% and 17% of patients on the active treatment had achieved a remission after six wee
ˆIn a less-resistant population we would expect to see higher responses,˜ said O’Reardon.
Although TMS treatments are typically given five times a week, patients usually need a minimum
When the FDA advisory panel met in January of this year to consider TMS, officials with the ag
There are still very few centers around the country that offer TMS as antidepression treatment
This is a demo version of txt2pdf v.10.1
Developed by SANFACE Software http://www.sanface.com/
Available at http://www.sanface.com/txt2pdf.html